Series C financing supports continued clinical development of the Acolyte™ Image-Guided coronary chronic total occlusion (CTO) platform, an FDA Breakthrough Device Company rebrands as Elumn8 Medical™ to better reflect expanded vision for image-enabled coronary interventions Progress continues in the Acolyte™ pre-market clinical trial CAMPBELL, Calif.–(BUSINESS WIRE)–Elumn8 Medical, Inc., formerly known […]